| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |